Effect of Hydroxymethylglutaryl-CoA Reductase Inhibitors on Low-Density Lipoprotein Cholesterol, Interleukin-6, and High-Sensitivity C-Reactive Protein in End-Stage Renal Disease. IJKD 2010, 5 (1), 29-33.